Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study
- DOI
- 10.3390/curroncol33090557
- Published
- 2026-09-15
- Container
- Current Oncology
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/curroncol33090557,
title = {Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study},
author = {Sławomir Milczarek and Oliwia Piotrowska and Bartłomiej Baumert and Ewa Borowiecka and Krzysztof Sommerfeld and Alina Hnatyszyn and Bogusław Machaliński},
year = {2026},
journal = {Current Oncology},
doi = {10.3390/curroncol33090557},
url = {https://doi.org/10.3390/curroncol33090557}
}RIS
TY - JOUR TI - Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study AU - Sławomir Milczarek AU - Oliwia Piotrowska AU - Bartłomiej Baumert AU - Ewa Borowiecka AU - Krzysztof Sommerfeld AU - Alina Hnatyszyn AU - Bogusław Machaliński PY - 2026 JO - Current Oncology DO - 10.3390/curroncol33090557 UR - https://doi.org/10.3390/curroncol33090557 ER -
APA
Milczarek, S., Piotrowska, O., Baumert, B., Borowiecka, E., Sommerfeld, K., Hnatyszyn, A., & Machaliński, B. (2026). Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study. Current Oncology. https://doi.org/10.3390/curroncol33090557
Source records
- crossref · retrieved 2026-09-26T06:25:03.338Z